ISRG Stock Overview
Develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Intuitive Surgical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$26.12 |
| 52 Week High | US$26.69 |
| 52 Week Low | US$26.09 |
| Beta | 1.4 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -0.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ISRG | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | -0.9% | -1.3% | 0.5% |
| 1Y | n/a | -13.1% | 20.9% |
Return vs Industry: Insufficient data to determine how ISRG performed against the Canadian Medical Equipment industry.
Return vs Market: Insufficient data to determine how ISRG performed against the Canadian Market.
Price Volatility
| ISRG volatility | |
|---|---|
| ISRG Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.6% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ISRG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ISRG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 13,676 | Gary Guthart | www.intuitive.com |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
Intuitive Surgical, Inc. Fundamentals Summary
| ISRG fundamental statistics | |
|---|---|
| Market cap | CA$233.60b |
| Earnings (TTM) | CA$2.83b |
| Revenue (TTM) | CA$10.24b |
81.3x
P/E Ratio22.5x
P/S RatioIs ISRG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISRG income statement (TTM) | |
|---|---|
| Revenue | US$7.57b |
| Cost of Revenue | US$2.51b |
| Gross Profit | US$5.06b |
| Other Expenses | US$2.97b |
| Earnings | US$2.09b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 17, 2024
| Earnings per share (EPS) | 5.89 |
| Gross Margin | 66.86% |
| Net Profit Margin | 27.65% |
| Debt/Equity Ratio | 0% |
How did ISRG perform over the long term?
See historical performance and comparison